Human CellExp Decorin /Bone proteoglycan II, human recombinant protein
Decorin, DCN, CSCD, DSPG2, PG40, PGII, PGS2, SLRR1B.
|Calculated MW||This protein fused with 6×His tag at the C-terminus, has a calculated MW of 38.8 kDa. The predicted N-terminus is Gly 17. DTT-reduced Protein migrates as 45 kDa or higher due to different glycosylation.|
|Other Names||Decorin, DCN, CSCD, DSPG2, PG40, PGII, PGS2, SLRR1B.|
|Results||Measured by its ability to modulate collagen fibrillogenesis. At 5 µg/mL, rh Decorin can significantly delay the rate of type I collagen fibrillogenesis.|
|Target/Specificity||Decorin /Bone proteoglycan II|
|Application Notes||Centrifuge the vial prior to opening. Reconstitute in sterile PBS, pH 7.4 to a concentration of 50 µg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 month. For extended storage, it is recommended to store at -20°C.|
|Storage||-20°C; Lyophilized from 0.22 µm filtered solution in PBS, pH 7.4. Normally Mannitol or Trehalose is added as protectants before lyophilization.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Decorin, also known as bone proteoglycan II, PGS2, SLRR1B, DCN, DSPG2 and PG40, is a secreted chondroitin /dermatan sulfate proteoglycan in the family of small leucine-rich proteoglycans (SLRPs). Decorin is a small cellular or pericellular matrix proteoglycan and is closely related in structure to biglycan protein. Decorin and biglycan are thought to be the result of gene duplication. This protein is a component of connective tissue, binds to type I collagen fibrils, and plays a role in matrix assembly. Decorin appears to influence fibrillogenesis, and also interacts with fibronectin, thrombospondin, the complement component C1q, epidermal growth factor receptor (EGFR) and transforming growth factor-beta (TGF-beta). Defects in DCN are the cause of congenital stromal corneal dystrophy (CSCD).
Krusius T.,et al.Proc. Natl. Acad. Sci. U.S.A. 83:7683-7687(1986).
Vetter U.,et al.Genomics 15:161-168(1993).
Danielson K.G.,et al.Genomics 15:146-160(1993).
Cs-Szabo G.,et al.Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
Kalnine N.,et al.Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
If you have any additional inquiries please email technical services at email@example.com.